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Abstract
In pigs, Chlamydia suis has been associated with respiratory disease, diarrhea and conjunc-
tivitis, but there is a high rate of inapparent C. suis infection found in the gastrointestinal tract
of pigs. Tetracycline resistance in C. suis has been described in the USA, Italy, Switzerland,
Belgium, Cyprus and Israel. Tetracyclines are commonly used in pig production due to their
broad-spectrum activity and relatively low cost. The aim of this study was to isolate clinical
C. suis samples in cell culture and to evaluate their antibiotic susceptibility in vitro under con-
sideration of antibiotic treatment on herd level.
Swab samples (n = 158) identified as C. suis originating from 24 farms were further pro-
cessed for isolation, which was successful in 71% of attempts with a significantly higher suc-
cess rate from fecal swabs compared to conjunctival swabs. The farms were divided into
three treatment groups: A) farms without antibiotic treatment, B) farms with prophylactic oral
antibiotic treatment of the whole herd consisting of trimethoprime, sulfadimidin and sulfathia-
zole (TSS), or C) farms giving herd treatment with chlortetracycline with or without tylosin
and sulfadimidin (CTS). 59 isolates and their corresponding clinical samples were selected
and tested for the presence or absence of the tetracycline resistance class C gene [tet(C)] by
conventional PCR and isolates were further investigated for their antibiotic susceptibility in
vitro. The phenotype of the investigated isolates was either classified as tetracycline sensitive
(Minimum inhibitory concentration [MIC] < 2 μg/ml), intermediate (2 μg/mlMIC < 4 μg/ml)
or resistant (MIC 4 μg/ml). Results of groups and individual pigs were correlated with antibi-
otic treatment and time of sampling (beginning/end of the fattening period). We found clear
evidence for selective pressure as absence of antibiotics led to isolation of only tetracycline
sensitive or intermediate strains whereas tetracycline treatment resulted in a greater number
of tetracycline resistant isolates.
Introduction
Since the 1940s, antibiotics have been prescribed in human and veterinary medicine to treat
bacterial infection, but only a few years after discovery of these antimicrobial drugs, the first
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cases of acquired antibiotic resistance emerged in the form of penicillin-resistant Staphylococ-
cus aureus [1]. Antibiotic resistance as a result of chromosomal mutation or acquisition of
resistance genes is promoted by numerous factors including a) the use of sub-inhibitory anti-
microbial concentrations (during treatment, as preventive measures or as growth promoters
in livestock), b) the use of broad-spectrum antibiotics, and c) non-compliance of individuals
and communities under treatment. Moreover, there is a positive correlation between the fre-
quency of antibiotic treatment and the occurrence of resistance [2]. Taken together, the use of
antibiotics exerts selective pressure against the microbial community promoting the emer-
gence of therapy-resistant bacteria [3]. However, selective pressure does not only concern
pathogens. Complex microbial ecosystems, in particular the microbiota of the gastrointestinal
tract, have been reported to regularly acquire and transfer antibiotic resistance genes, often
promoted by the use of oral antimicrobial drugs. With high bacterial loads of 1011 to 1012 bac-
teria/ml from several phyla, the colon offers plenty of opportunity for horizontal gene transfer
and the selection for commensal bacteria resistant to antibiotics [4, 5].
Of particular interest in this wide range of commensal and opportunistic bacteria is the spe-
cies Chlamydia suis, which is primarily found in the gastrointestinal tract of pigs and was the
first obligate intracellular bacterium reported to have acquired stable tetracycline resistance
through horizontal gene transfer [6, 7]. C. suis belongs to the Chlamydiaceae, a family of
Gram-negative bacteria which also includes C. trachomatis, the leading cause of sexually trans-
mitted bacterial disease worldwide as well as the causing agent of blinding trachoma [8].
Despite its high prevalence in pigs, with up to 94.2% in farms, C. suis is not considered a pri-
mary pathogen for pigs, but it has been associated with several disease complexes including
conjunctivitis as well as reproductive disorders, and cases of diarrhea within the herd related
to a high C. suis prevalence [9, 10]. The tetracycline resistance found in C. suis is defined by the
presence of an efflux pump encoding gene called tetracycline resistance gene class C [tet(C)]
within a genomic island [7], though its presence does not necessarily translate into antibiotic
resistance in vitro [11]. C. suis strains carrying the tet(C) gene have been identified in several
pig farms in the USA, Italy, Switzerland, Belgium, Cyprus and Israel in recent years [7, 12–14,
15]. Moreover, there has been preliminary evidence for selective pressure as a result of antibi-
otic treatment in C. suis-infected pigs [13].
In this study, we used 158 swab samples from a vast collection of over 2000 fecal and con-
junctival swabs originating from 29 farms [9]. We found that 1) the estimated number of gene
copies in a clinical sample by real-time PCR is a good predictor to assess successful isolation,
and 2) isolation from conjunctival swabs is far less successful compared to fecal samples sug-
gesting that fecal contamination rather than actual conjunctival infection occurred. A selection
of isolates (n = 59) were further tested for tet(C) by PCR as well as their antibiotic susceptibility
in vitro, confirming previous findings that positive tet(C) results do not necessarily mean that
the isolate is also phenotypically resistant [11]. Furthermore, we show that the number of tetra-
cycline resistant C. suis isolates in pigs treated with tetracycline derivatives tends to increase
between the beginning and end of the fattening period, whereas farms where no antibiotic
treatment was applied only yielded tetracycline sensitive or intermediate C. suis isolates, pro-
viding evidence for selective pressure.
Material and Methods
Sample collection and study design
Between December 2014 and September 2015, samples were collected from 636 pigs in 29
farms in the central part of Switzerland. Each pig was sampled at the beginning (first sampling)
and end (second sampling) of the fattening period (total fattening period of around 3 months).
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Abbreviations: C., Chlamydia; CTS (Group C),
Chlortetracycline with or without tylosin and
sulfadimidin (antibiotic treatment on herd level);
EMEM, Eagle’s minimum essential medium; FCS,
Fetal calf serum; Group A, No antibiotic treatment
on herd level; Group B (TSS), see TSS (Group B);
Group C (CTS), see CTS (Group C); Inclusion-
forming units per mililiter, IFU/ml; MIC, Minimum
inhibitory concentration; MBC, Minimum
bactericidal concentration; rRNA, ribosomal
ribonucleic acid; SP transport medium, sucrose
phosphate transport medium; Tet(C), Tetracycline
resistance class C gene; TSS (Group B),
Trimethoprime, sulfadimidin and sulfathiazole
(antibiotic treatment on herd level).
Two conjunctival (both eyes, pooled) and two fecal swabs (FLOQSwabs1, Copan Italia, Bre-
scia, Italy) were collected per sampling (two timepoints), of which one swab per anatomical
site was used for DNA extraction and the other was stored at—80˚C in sucrose phosphate
transport medium, resulting in a total of eight flocked swabs per pig [9].
In the present study 158 swab samples [9], comprising 21 conjunctival and 137 fecal swabs
belonging to 24 farms, were further processed for isolation. The farms were divided into three
groups: A) farms without antibiotic treatment (n = 16) and B) farms prophylactically treating
the whole herd with trimethoprime, sulfadimidin and sulfathiazole (TSS, n = 3), or C) chlortet-
racycline with or without tylosin and sulfadimidin (CTS, n = 5) (S1 Table). A selection of iso-
lates (n = 59) and their corresponding clinical samples were tested for the presence or absence
of the tetracycline resistance class C gene [tet(C)] by conventional PCR and were further inves-
tigated for their antibiotic susceptibility, as described in detail below (Fig 1).
Host cells and media
The isolation of swab samples and antibiotic susceptibility assays were performed in
LLC-MK2 cells (continuous Rhesus monkey kidney cell line, provided by IZSLER Brescia,
Italy) grown on glass coverslips (Ø 12 mm) in 7 ml Trac bottles (Thermo Fisher Scientific,
Waltham, MA, USA) at 37˚C and 5% CO2.
Cells were maintained in growth medium containing 500 ml Eagle’s minimum essential
medium (EMEM, Gibco, Thermo Fisher Scientific, Invitrogen, Carlsbad, CA, USA) supple-
mented with 10% heat-inactivated fetal calf serum (FCS, BioConcept, Allschwil, Switzerland),
0.6 ml fungizone (250 μg/ml) (Gibco), 0.1 ml gentamycin (50 mg/ml) (Gibco), 0.5 ml vanco-
mycin (10 mg/ml) (Gibco) and 6 ml glucose (0.06 g/ml) (Sigma-Aldrich Co., St. Louis, MO,
USA). Following infection, growth medium was replaced by chlamydiae cultivation medium
consisting of 500 ml EMEM supplemented with 20% FCS (BioConcept), 5 ml L-glutamine
(Gibco, Thermo Fisher Scientific), 4 ml fungizone (250 μg/ml), 0.5 ml gentamycin (50 mg/ml),
5 ml vancomycin (10 mg/ml), 2 g D-(+)-glucose (Sigma-Aldrich) and 0.7 ml cycloheximide
(1 mg/ml) (Sigma-Aldrich) as described by Donati et al. [16].
Fig 1. Study Design. Shown is the study design as well as the sample numbers used for each method applied in this study and that of
Hoffmann et al. [9].
doi:10.1371/journal.pone.0166917.g001
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Clinical samples for isolation were frozen and stored in sucrose phosphate (SP) transport
medium consisting of 37.5 g sucrose, 0.2 M Na2HPO4-2H2O and 0.2 M Na2PO4-2H2O in 500
ml ddH2O. Isolates for the antibiotic susceptibility assay were stored in SP supplemented with
160 μl fungizone (final concentration: 2 μg/ml), 80 μl gentamycin (200 μg/ml) and 40 μl vanco-
mycin (100 μg/ml).
Isolation of Chlamydia
Fecal (n = 137) and conjunctival (n = 21) swabs, originally sampled in 400 μl SP medium and
stored at– 80˚C, were chosen for isolation. Isolates obtained from the pigs in this study were
the same samples that were collected previously as described by Hoffmann et al. [9].
Specifically, at a cell confluence of 100%, swab samples were thawed, vortexed for 1 min
and inoculated onto LLC-MK2 cells in triplicate (~ 133.3 μL) together with chlamydiae cultiva-
tion medium (final volume per Trac bottle: 2 ml) before centrifugation for 2 hours at 2385 g
(33˚C). After an incubation period of 48 h (37˚C, 5% CO2), one Trac bottle from each sample
was fixed in methanol for 10 min before detection of intracellular chlamydial inclusions by
immunofluorescence assay (IFA) with a DMLB fluorescence microscope (Leica Microsystems,
Wetzlar, Germany). Briefly, monolayers were air-dried and placed onto a paraffin-embedded
plate mounted with 5 μL fluorescein-conjugated monoclonal antibody specific for the chla-
mydial LPS genus-specific antigen (IMAGEN Chlamydia K610111-2, Thermo Fisher Scien-
tific). After 30 min incubation at 37˚C, coverslips were washed three times in PBS and fixed
onto glass slides using FluoreGuard Mounting (Hard Set, ScyTek Laboratories Inc., Logan,
UT, USA).
For monolayers with visible inclusions, the remaining Trac bottles of the corresponding
sample were passaged by vortexing and inoculation of new monolayers until the rate of chla-
mydial infection achieved 80–100%. Successfully isolated strains were then frozen in SP
medium with antibiotics (gentamycin, vancomycin and fungizone), heat-treated FCS or sterile
PBS and stored at—80˚C or—20˚C for further investigation.
Cultures were considered negative for viable Chlamydia if no inclusions were detected after
three passages.
Confirmation of chlamydial species
DNA extraction and real-time PCR for Chlamydiaceae. DNA of isolated stocks was
extracted using the QIAamp DNA mini kit (Qiagen, Hilden, Germany), following the suppli-
er’s recommendations. All samples were examined using real-time PCR based on Chlamydia-
ceae family-specific 23S rRNA gene primers performed on an ABI 7500 instrument, as
previously described [17, 18].
All samples were tested in duplicate and the cycle threshold was set at 0.1 for each run. A
mean cycle threshold (Ct value)< 38 was considered positive, and was used to calculate the
corresponding chlamydial load as Chlamydiaceae 23S rRNA gene copy number per μl. If the
amplification of internal control DNA was inhibited, the run was repeated following 1:10 dilu-
tion of the sample. The positive control contained a sevenfold dilution series of C. abortus
DNA and a negative control of water instead of the template DNA was included in each run
[9].
Arraymate Microarray for species identification. All samples with positive results in the
real-time PCR were further investigated using a species-specific 23S rRNA Arraymate micro-
array assay (Alere, Jena, Germany), as established by [19]. The current version carries 34
probes for eleven Chlamydiaceae species, three genus-specific probes, four family markers and
15 probes for Chlamydia–like organisms. Additionally, there are four internal control DNA
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probes and an internal staining control (biotin marker) [9]. Each sample, including internal
control DNA (Intype IC-DNA, Qiagen Labor, Leipzig, Germany), was amplified and biotin-
labeled using a biotinylation PCR, as described by Borel et al. [19], with 10 min of initialization
(96˚C) and 40 cycles of 94˚C (denaturation), 50˚C (annealing), and 72˚C (elongation) for 30 s
each. 2–4 μl of amplification product was loaded on the chip, which was processed according
to manufacturer’s instructions.
Tet(C) PCR. DNA of 59 isolates and their corresponding clinical samples were screened
with an established PCR amplifying a 525 bp fragment of the tet(C) gene according to Dugan
et al. [7]: CS43 (5’-AGCACTGTCCGACCGCTTTG-3’) and CS47 (5’-TCCTCGCCGAAAAT
GACCC-3’). 5 μl DNA per sample was added to a PCR mixture (final volume 50 μl) contain-
ing 1.5 U AmpliTaq Gold DNA polymerase (Applied Biosystems/Roche), 2.0 mM magnesium
chloride, 200 μM of each deoxynucleoside triphosphate, 1x Gold Buffer and 20 pmol of each
primer. Cycling conditions consisted of initial denaturation (4 min, 94˚C) followed by 40
cycles of denaturation (94˚C), annealing (55˚C) and chain elongation (72˚C) for 1 min each.
The reaction was completed with a final elongation step (72˚C) for 7 min.
Antibiotic susceptibility
Titration by sub-passage was performed on all the isolates (n = 59, stored in SP medium).
Briefly, chlamydiae-containing SP media were sonicated for 5 min (Brandson 250 Sonifier,
Danbury, CT, USA), inoculated onto 100% confluent LLC-MK2 cells in Trac bottles at a
10-fold dilution and centrifuged at 2385 g (33˚C) for 1 h. After 48 h incubation at 37˚C in the
presence of 5% CO2, cultures were fixed and immunolabeled. For analysis, the number of
inclusions at 200-fold magnification throughout the entire coverslip was counted and used to
determine the number of inclusion-forming units per milliliter (IFU/ml). Each antibiotic sus-
ceptibility determination was performed with approximately 5 x 103 IFU/ml per investigated
isolate as previously described [11].
Following inoculation of 16 confluent monolayers, Trac bottles were centrifuged at 2385 g
(33˚C) for 1 hour, inocula were removed and replaced with chlamydiae cultivation medium
containing a serial two-fold dilution of tetracycline (Sigma-Aldrich) at concentrations ranging
from 0.06 μg/ml to 4 μg/ml. Each tetracycline concentration was added in duplicate. Following
incubation at 37˚C for 48 h, one infected monolayer per tetracycline concentration was fixed
with methanol, and immunolabeled, as described above (Material and Methods section). The
minimum inhibitory concentration (MIC) of tetracycline was defined as “the lowest concen-
tration preventing the detection of more than 90% of the chlamydial inclusions compared with
the drug-free control” [11, 16]. In parallel, media of the remaining Trac bottles was replaced
with tetracycline-free chlamydiae cultivation medium after washing the coverslips with PBS.
Monolayers were fixed after 48 h of incubation and immunolabeled for the evaluation of the
minimum bactericidal concentration (MBC), which was identical to MIC determination. C.
suis isolates with a MIC/MBC of 4 μg/ml were defined as resistant, whereas cultures with
2 μg/mlMIC/MBC < 4 μg/ml were considered intermediate and isolates with a MIC/MBC
of< 2 μg/ml were sensitive.
Statistical analysis
The online calculator N-1 Two Proportion test (http://www.measuringu.com/ab-calc.php) was
used to compare the isolation success regarding swab origin (rectal or conjunctival swab) and
the chlamydial load. The calculator is based on a two-tailed chi-square test. A p-value < 0.05
was considered significant.
Tetracycline Resistance and Chlamydia Suis
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Results
High bacterial loads result in more successful isolation
Isolation was considered successful if chlamydial inclusions were detected after 1 to 3 passages
by immunofluorescence assay. Subsequently, species confirmation was performed by real-
time PCR and Arraymate microarray. In this study, 113 of the 158 Chlamydia positive swabs
produced Chlamydia-positive cultures, resulting in a success rate of 71.5% (Table 1). Interest-
ingly, there was a significant difference between the success of the conjunctival swabs
(p-value < 0.05), with only one isolate out of 21 samples (4.8%) and fecal swabs where the suc-
cess rate was 82.5%.
We then proceeded to investigate these results by using the estimated chlamydial load from
each clinical swab, as determined by real-time PCR to compare successful with unsuccessful
isolations [9]. We further differentiated between fecal and conjunctival swabs. The distribution
of copy numbers per sample was expressed by means of a boxplot, which clearly demonstrates
that the general bacterial load of conjunctival swabs was lower compared to fecal swabs (Fig 2).
Since the copy numbers per μl depend on the number of cycles in the Chlamydiaceae real-time
PCR, they were expressed in a logarithmic scale leading to the exclusion of samples with mean
copy numbers of less than 1 per μl (n = 15) for this analysis. Also excluded from this analysis
Table 1. Number of successful isolations and success rates depending on swab origin.
Successful Isolations All Samples Success Rate [%]
Conjunctival Swabs 1 21 4.8
Fecal Swabs 112 137 82.5
All Swabs 113 158 71.5
doi:10.1371/journal.pone.0166917.t001
Fig 2. Comparison between the bacterial load of successful and failed isolations, depending on the
anatomical site of sampling. Bacterial load of the clinical samples used for isolation expressed as 23S rRNA
gene copy numbers per μl in a logarithmic scale (ln). The bacterial load of successfully isolated clinical swabs
is compared to unsuccessful isolations while fecal and conjunctival swabs are presented separately.
doi:10.1371/journal.pone.0166917.g002
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were samples used for isolation where DNA of corresponding clinical swabs had to be diluted
10-fold in order to successfully perform the real-time PCR due to high bacterial loads (n = 13).
Fig 2 also indicates that the bacterial load of successful isolations was slightly higher com-
pared to unsuccessful isolations. We decided to investigate this hypothesis by classifying the
bacterial load of samples into four different groups: a) less than (<) 1, b) 1 to 100, c) 100 to 700
and d) more than (>) 700 copy numbers per μl, as shown in Table 2. For this analysis, we
included all samples used for isolation by making the assumption that the 13 samples, of which
a 10-fold dilution had to be performed, yielded more than 700 DNA copy numbers per μl.
Eight of the diluted samples even yielded more than 700 copies, while four generated between
100 and 700 copies per μl, and one had only 39.7 copies per μl (S1 Table). The isolations from
these samples were altogether successful.
Using this classification, we were able to show that the isolation success correlated with the
bacterial load. In detail, while less than 50% of all isolation attempts were successful if the cor-
responding clinical swabs yielded between 1 and 100 copy numbers per μl, the success rate of
swabs yielding over 700 copies per μl was 95.5% (Table 2, S1 Table). The isolation success of
swabs with over 700 copies per μl was significantly higher than that of swabs with fewer than
700 copies per μl (p< 0.05).
Tet(C) PCR does not correlate with the in vitro phenotype
A recent publication has demonstrated that positive PCR results do not necessarily translate
into a tetracycline resistant phenotype by means of an antibiotic susceptibility assay [11]. In
view of these findings, we selected 59 C. suis isolates, analyzed their tetracycline susceptibility
in vitro and subsequently compared them to the presence or absence of the tet(C) gene by
PCR.
An isolate was considered tet(C)-positive if a band was present on the gel at 525 base pairs
(bp) following amplification of the gene by PCR (S1 Fig). In total, 32 isolates were positive
for tet(C), while 27 were negative. Regarding the antibiotic susceptibility assay, both the MIC
and MBC were evaluated. The phenotype of investigated isolates was either classified as tetra-
cycline sensitive (MIC < 2 μg/ml), or intermediate (2 μg/mlMIC < 4 μg/ml) or resistant
(MIC 4 μg/ml), depending on the MIC concentration. In total, 31 out of the 59 investigated
isolates were phenotypically sensitive (52.5%), six were considered intermediate (10.2%), while
22 were tetracycline resistant (37.3%) by the antibiotic susceptibility assay. Compared to MIC,
the MBC values were generally higher by 0 to 0.5 μg/ml and 1.5 μg/ml in one case (S2 Table).
Interestingly, while all phenotypically resistant isolates were also positive by the tet(C) PCR
(22 / 22) as expected, sensitive or intermediate phenotypes could be both tet(C)-positive or
negative. In fact, while 26 out of 31 phenotypically sensitive isolates tested tet(C)-negative,
only one intermediate isolate was negative for tet(C) (Fig 3).
Since the antibiotic susceptibility assay allows us to determine the number of C. suis inclu-
sions at different concentrations of tetracycline in vitro, it is a more precise parameter to
evaluate the actual biological behavior of chlamydial isolates in the presence of antibiotics.
Excluding all isolates with an intermediate phenotype, the positive predictive value of the
Table 2. Successful isolation in relation to the copy numbers per μl of clinical swab samples.
Copy numbers per μl < 1 1–100 100–700 > 700
Successful Isolation (n = 113) 4 18 28 63
Unsuccessful Isolation (n = 45) 11 20 11 3
Success Rate [%] 26.7 47.4 71.8 95.5
doi:10.1371/journal.pone.0166917.t002
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tet(C) PCR is 81.5% compared to the phenotype and only 68.8% if the intermediate phenotype
is included. In contrast, the negative predictive value of the tet(C) PCR was 100% indicating
that all phenotypically resistant C. suis isolates carry the tet(C) gene (Fig 4).
Tet(C) PCR performed directly from clinical swabs strongly increases the
number of false negative results
So far, we have been able to show that tet(C)-negative results translate into a sensitive or inter-
mediate phenotype in vitro. However, we used chlamydial DNA extracted from the isolates for
these tests. In a second step, we aimed to investigate whether tet(C) PCR from clinical swabs
yielded similar results.
Interestingly, out of 32 isolated samples positive for tet(C), only 16 corresponding clinical
swabs were positive resulting in a sensitivity of only 50% and a negative predictive value of
62.8% for clinical swabs. In contrast, all the tet(C) PCR negative isolates were also negative in
the corresponding clinical samples (Fig 5).
Fig 3. Tetracycline susceptibility assay (MIC in μg/ml) compared to tet(C) PCR. Shown are the tet(C)
results by PCR (positive or negative) in the y-axis compared to the tetracycline susceptibility in vitro (MIC
in μg/ml) in the x-axis for each individual isolate (n = 59). The in vitro phenotype is divided into three groups:
sensitive (MIC < 2 μg/ml), intermediate (2MIC < 4 μg/ml) and resistant (MIC 4 μg/ml).
doi:10.1371/journal.pone.0166917.g003
Fig 4. Validity and predictive values of the tet(C) PCR compared to in vitro susceptibility. Shown are the validity
(sensitivity, specificity) and the predictive values of the tet(C) PCR compared to the phenotype by antibiotic susceptibility
assay in vitro. The upper left panel and the middle column show the comparison between the resistant phenotype
(MIC 4 μg/ml) and the sensitive or intermediate phenotype (MIC < 4 μg/ml). The upper right panel and the right column
compare the resistant with only the sensitive phenotype (MIC < 2 μg/ml).
doi:10.1371/journal.pone.0166917.g004
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Taken together, clinical swab samples are more frequently negative for tet(C) (n = 43) com-
pared to isolated samples (n = 27), resulting in a greater number of false negative results. Fur-
thermore, it must be noted that out of the 10 positive tet(C) results from either phenotypically
sensitive or intermediate isolates mentioned in Fig 3, six were also positive in the clinical swab.
Therefore, PCR analysis of clinical samples does not necessarily reduce the number of false
positives.
Isolates from pigs without antibiotic treatment were never phenotypically
resistant
In Switzerland, prophylactic and metaphylactic oral antimicrobial treatment of fattening pigs
is common [9]. In particular, tetracycline and tetracycline derivatives, as broad-spectrum anti-
biotics, have been used extensively in the pig industry for both prophylactic and therapeutic
treatment [20]. As expected from previous publications [13], we found that farms treating pigs
with oral tetracycline derivatives (CTS, Treatment Group C) harbored the most phenotypically
resistant C. suis cultures with 18 out of 26 isolated samples (64.3%) (S2 Table). Of the remain-
ing samples, six isolates were sensitive and two were intermediate. Farms without oral antimi-
crobial treatment during the fattening period (Treatment Group A) did not harbor any
resistant isolates. Of 18 investigated cultures, 16 were sensitive and two belonged to the inter-
mediate phenotype (S2 Table). Interestingly, from farms that treated their animals with tri-
methoprime, sulfadimidin and sulfathiazole (TSS, Treatment Group B), a highly diverse
population of different Chlamydia-positive cultures was isolated. Out of 15 isolates tested in
vitro, four were phenotypically resistant, nine were sensitive and two intermediate (S2 Table).
Oral treatment with tetracycline during the fattening period increases the
incidence of resistance in pig farms
Pigs were sampled both at the beginning (first sampling) and end (second sampling) of the fat-
tening period [9]. We compared the in vitro phenotype of isolates obtained at the first with iso-
lates obtained at the second sampling timepoint under consideration of the three treatment
groups. For Treatment Group A (no antibiotics), the tetracycline susceptibility of 18 isolates
originating from eleven pigs was determined, which resulted in nine phenotypically sensitive
and one intermediate isolates at the first as well as seven sensitive and one intermediate pheno-
type at the second sampling. Interestingly, the four phenotypically resistant isolates originating
from pigs in Group B (TSS) were altogether obtained at the first sampling. At the end of the
fattening period, only the sensitive (n = 8) or intermediate (n = 1) phenotype was present.
Within Group C (CTS), there was an increase of tetracycline resistant and a decrease of pheno-
typically sensitive isolates between the first and second sampling. In detail, only three out of
eight investigated pigs harbored phenotypically resistant isolates (37.5%) at the first sampling
Fig 5. Presence of tet(C) in clinical swabs in comparison to their corresponding isolated samples. The left panel
compares the tet(C) PCR values of the corresponding clinical sample (y-axis) with that of the isolate (x-axis) for each
individual sample. The right panel displays the validity and predictive values for this comparison.
doi:10.1371/journal.pone.0166917.g005
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while 15 out of 18 isolates were resistant in the antibiotic susceptibility assay at the second col-
lection (83.3%). Furthermore, whereas five tetracycline sensitive isolates were obtained at the
first sampling, only one was present at the second sampling. Additionally, two intermediate
isolates were collected at the second sampling (Fig 6).
To further confirm these findings, individual pigs were selected of which successful isola-
tion was performed both at the first and second sample collection resulting in 36 paired iso-
lates originating from 18 pigs. In Group A (seven pigs), sensitive (n = 6) and intermediate
(n = 1) phenotypes were present at the first sampling while only sensitive isolates remained at
the second sampling. Individual pigs within Group B (six pigs) confirmed the previous obser-
vation that isolates could be phenotypically resistant at the first collection but cultures obtained
from the same pig were sensitive at the second sampling (n = 4). Within Group C (five pigs),
three out of five pigs harbored resistant isolates at both collection timepoints, whereas two pigs
contained phenotypically sensitive isolates at the first and the intermediate or resistant pheno-
type at the second sampling (S3 Table).
Discussion
Growing numbers of antibiotic resistant pathogens have caused the Swiss Federal Office of
Public Health to specifically target and monitor the consumption of antibiotics in human and
veterinary medicine [21]. This strategy was developed in addition to the total ban on the use of
antibiotic growth promoters in livestock initialized by Sweden in 1986, implemented by Swit-
zerland in 1999 and followed by the European Union (EU) in 2004 [22, 23].
The first tetracycline resistant C. suis strains were reported in USA pig farms in the early
1990s [7]. The relatively inexpensive tetracycline and tetracycline derivatives with broad spec-
trum activity are the most commonly used antibiotics with more than 6500 tons approved for
domestic use in food-producing farm animals in 2014 in the USA [24].
In the current study, we aimed to compare the tetracycline susceptibility in vitro of porcine
clinical samples with the presence or absence of the tet(C) gene, which required isolation of
various C. suis samples previously identified by real-time PCR and subsequent species identifi-
cation by Arraymate microarray [9]. We found that two factors mainly influenced the success
of our isolation attempts: the bacterial load as estimated by quantitative real-time PCR, and the
sampled anatomical site (rectal versus conjunctival).
Fig 6. In vitro phenotypes within individual treatment groups at the first and second sampling. Shown
is the phenotype in vitro (sensitive, intermediate, resistant) of each investigated isolate as estimated by
antibiotic susceptibility assay under consideration of the sampling timepoint (first sampling at the beginning,
second sampling at the end of the fattening period) and which treatment group the sampled pig belonged to: A
(no antibiotics), B (TSS) or C (CTS).
doi:10.1371/journal.pone.0166917.g006
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Petayaev et al. [25] showed that as few as 200 copies per ml by quantitative TaqMan PCR
were enough to successfully isolate C. pneumoniae from the sera of patients with acute coro-
nary syndrome. In contrast to these findings, fewer than 1000 copies per ml (< 1 copy per μl)
resulted in a success rate of only 25% in our study. However, it must be taken into consider-
ation that, with C. pneumoniae and C. suis, two different chlamydial species were chosen for
isolation and that quantification was performed with two different primer pairs, specifically a
C. pneumoniae-specific and a more general Chlamydiaceae primer pair targeting a 194 bp frag-
ment of the 16S rRNA and a 111 bp fragment of the 23S rRNA gene, respectively [18, 25]. Sam-
pling inconsistencies such as insufficient insertion of the flocked swabs used for PCR analysis
into the rectum/conjunctival sac or subsequent failure of the DNA extraction could explain
these findings. Sampling inconsistencies could also explain the five samples with over 700 cop-
ies per μl that could not be isolated. Taken together, our findings confirm previous publica-
tions showing that, while quantitative PCR is highly sensitive, it does not differentiate viable
from non-viable pathogens. In Mycobacteria, for example, a close linear correlation between
quantitative real-time PCR and the conventional colony counting method has been demon-
strated, showing that the colony counts are consistently below real-time PCR estimates [26].
As estimated by Hoffmann et al. [9], the mean number of Chlamydia 23S rRNA gene copies
per μl is significantly lower for conjunctival swabs compared to fecal swabs. Different bacterial
loads depending on the anatomical site and nature of sampling has also been demonstrated in
a recent review systematically analyzing 29 publications on human genital Chlamydia infection
involving over 40,000 participants where rectal swabs yielded the highest load for male patients
contrasting females where cervical swabs clearly resulted in the highest bacterial load [27].
However, the low bacterial load alone does not explain the differences in the success rates of
isolating from conjunctival or fecal swabs: out of the 15 swabs with fewer than 1 copy per μl, all
four successfully obtained isolates originated from fecal swabs. These findings confirm previ-
ous results showing no correlation between the presence of conjunctivitis and chlamydial posi-
tivity [9]. In contrast, successful isolation of conjunctival swabs originally collected from
asymptomatic pigs with only a history of conjunctivitis but not active infection has been dem-
onstrated in another study [11]. Therefore, given the low bacterial load of our samples and that
isolation from conjunctival swabs has succeeded before, we suggest that fecal contamination
rather than active infection of the conjunctiva with viable bacteria was present in the pigs sam-
pled in this study.
C. suis isolates were tested for their antibiotic susceptibility in vitro in order to identify the
phenotype (sensitive, intermediate, resistant) as well as the presence or absence of the tet(C)
gene by PCR. For most bacteria, antimicrobial susceptibility testing in vitro has been the gold
standard to detect potential antibiotic resistance, although PCR-based techniques have been
established in recent years. However, one of the primary constraints of this detection method is
that the presence of a resistance gene does not automatically translate into resistant phenotypes
in vitro and that alternative resistance mechanisms may be present [28]. Interestingly, only one
form of tetracycline resistance in C. suis has been reported to date. Furthermore, the in vitro
susceptibility test of Chlamydia to antimicrobials is not affordable for all laboratories as it is a
time-consuming assay. Consequently, tet(C) PCR is more commonly used for detection than
the antibiotic susceptibility assay [15, 29]. In the current study, we found clear evidence for the
benefit of isolating samples prior to molecular analysis over tet(C) PCR directly from clinical
swabs as well as the superiority of the tetracycline susceptibility assay with and without PCR
analysis over tet(C) detection alone. First, while all phenotypically resistant isolates were posi-
tive for tet(C), there were a substantial number of false positive tet(C) results for phenotypically
sensitive or intermediate isolates. These findings indicate that the presence of the tet(C) gene in
C. suis is not necessarily associated with tetracycline resistant phenotype in vitro confirming
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findings of a recent publication from Italy [11]. False positive tet(C) results may have been
caused by confounding genetic factors or the presence of other tetracycline resistant bacteria
belonging to the gut microbiota [4, 5]. Moreover, co-infection with multiple strains originating
from the same species has been reported in other Chlamydia species [30, 31]. Although isola-
tion and cultivation is known to alter and select specific strains [30, 32], isolation does not guar-
antee the presence of clonally pure C. suis strains. It is therefore possible that mixed infections
of sensitive and resistant strains occurred. Clonal purification and subsequent whole-genome
sequencing for confirmation is necessary to ensure the complete absence of mixed infection.
Second, the antibiotic susceptibility assay allows a tripartite classification system identifying
sensitive, intermediate and resistant isolates as commonly implemented in routinely applied
susceptibility profiles for extracellular bacteria [33] leading to a more nuanced classification as
opposed to a positive or negative result for the presence of tet(C). The importance of imple-
menting a tripartite classification is particularly obvious if we consider that the rate of false pos-
itive tet(C) results is considerably higher for the intermediate (2 μg/mlMIC< 4 μg/ml) than
the sensitive (MIC< 2 μg/ml) phenotype. Third, we compared tet(C) results of DNA extracted
from the isolates with their corresponding clinical swab samples to evaluate the test accuracy of
tet(C) of uncultured clinical samples because it would be a time-saving alternative to isolation
of samples in cell culture. We found that the frequency of false negative results in the clinical
swab samples was very high, possibly due to low bacterial loads before isolation or PCR inhibi-
tors within the clinical sample. In conclusion, PCR analysis of clinical swabs alone is not suit-
able to evaluate the prevalence of tetracycline resistant C. suis strains in a herd.
We investigated the effect of antibiotic treatment on the susceptibility of isolates originally
sampled both at the beginning and end of the fattening period originating from pigs belonging
to treatment groups A (no antibiotics), B (TSS) or C (CTS). As expected, the distribution of
phenotypically resistant and sensitive isolates depended on the treatment groups. However,
even under consideration of selective pressure [34], it is still striking that untreated pigs har-
bored strains exhibiting only the sensitive or intermediate phenotype as opposed to pigs
treated with chlortetracycline, where the majority of tetracycline resistant samples were iso-
lated both at the beginning and especially at the end of the fattening period. These findings
offer clear evidence for the impact of selective pressure in terms of tetracycline resistance in C.
suis and confirm previous results of a small-scale study where conjunctival swabs were taken
both at the beginning and end of the fattening period. The swabs originated from randomly
selected pigs with signs of conjunctivitis and were tested for the presence or absence of tet(C)
before and after tetracycline treatment resulting in a clear increase of tet(C) positive clinical
samples between the first and second sampling [13].
Despite a great number of publications investigating tetracycline resistance in C. suis, only
two studies have analyzed samples at two or more different points in time [12, 13]. This is the
first study additionally investigating the same pig both before and after antibiotic treatment
(paired sampling). Identification of individual pigs at both samplings was possible with the
help of the official identification number of the pig. Paired samples from pigs treated with
chlortetracycline confirmed the hypothesis of selective pressure as they harbored tet(C) either
already at the first sampling or acquired it during the fattening period. Similarly, only the sen-
sitive phenotype was found at the second sampling for Group A giving further indication that
tetracycline treatment leads to the selection of tetracycline resistant C. suis strains.
One possible explanation for the occurrence of tetracycline resistant C. suis already at the
beginning of the fattening period is that the pigs acquired these strains before they were
brought into the farms, probably during the weaning period. Another important aspect is the
fact that most farms buy their fattening pigs from various weaning farms. This increases the
risk of cross-contamination through reported fecal-oral transmission [35] between pigs from
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different farms within the first days after entry. As a result, farrow-to-finish farms are known
to have a lower risk of Chlamydiaceae infection [9] as well as acquisition or transfer of tetracy-
cline resistance across the herd.
Unexpected among our findings, the majority of the paired samples in group B (TSS)
changed their phenotype from resistant to sensitive after oral group treatment. All Chlamydia
spp. are resistant to trimethoprim. However, C. trachomatis and C. suis are susceptible to sul-
fonamides, whereas C. pneumoniae and C. psittaci are resistant [36, 37]. There are several pos-
sibilities to explain the disappearance of resistant C. suis isolates in this treatment group. For
example, the sulfonamides may have eradicated all active C. suis infections with subsequent
reinfection of sensitive strains. Another hypothesis is predominance of sensitive strains in
group B due to the lack of appropriate selective pressure during the fattening period as resis-
tance is often associated with reduced bacterial fitness [34]. Sensitive C. suis strains may domi-
nate in the absence of tetracycline.
In order to fully understand the interaction between the resistant and sensitive phenotype,
the presence as well as expression of tet(C) and the true dynamics of C. suis infection during
the fattening period, possible mixed infection and reinfection, further experimental studies
and genomic analyses are necessary.
In summary, the current study demonstrates that two factors are important for successful
isolation: the bacterial load and anatomical site. There was a positive correlation between the
bacterial load and success of isolation, while fecal swabs were used more successfully for isola-
tion compared to conjunctival swabs. We present further evidence that the presence of tet(C)
does not automatically translate into a resistant phenotype and that the antibiotic susceptibility
assay is more reliable than molecular methods to predict the biological behavior of isolates
under antibiotic treatment. Additionally, we found evidence for the benefit of isolation over
analysis directly from swab samples to reduce the number of false negative tet(C) results. Finally,
we show that absence of tetracycline treatment prevents or at least massively reduces the inci-
dence of tetracycline resistant isolates, while treatment promotes the presence of resistance. In
contrast, while the combination of trimethoprime, sulfadimidin and sulfathiazole was unable to
clear infections on herd-level, it clearly reduced the number of tetracycline resistant isolates.
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